ENvue Medical (FEED) announced the launch of a new development and integration program leveraging vibration-based technology from its NanoVibronix division to address pain and discomfort associated with indwelling nasogastric tubes. Doron Besser, MD, CEO of ENvue Medical, commented, “We believe that this program represents a disciplined platform expansion initiative focused on improving the overall enteral care experience by addressing patient comfort during prolonged NG tube use. While this initiative is exploratory in nature and does not represent a commercial product launch or regulatory clearance announcement, we believe the data will be invaluable for our ongoing commercial efforts of our technology.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on FEED:
